|
SION Sionna Therapeutics Inc 2036042 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-26,779,000.00 |
| Balance Sheet |
|
Current Assets
|
$220,959,000.00 |
|
Assets
|
$305,039,000.00 |
|
Current Liabilities
|
$9,776,000.00 |
|
Liabilities
|
$16,831,000.00 |
|
Equity
|
$288,208,000.00 |
|
Shares Out
|
45075651.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-21,840,000.00 |
|
Investing Cash Flow
|
$24,820,000.00 |
| Market Analysis |
Market Cap
|
$2,108,638,953.78 |
|
Price
|
$45.85 |
|
BVPS
|
6.39 |
|
PB
|
7.32 |
|
EPS
|
-0.60 |
|
FCF
|
$-21,840,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:23 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:19 |
|
| Apr |
May |
Jun |
| 2026-03-02 |
-0.46 |
|
|
2026-05-12 |
-0.60 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.41 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.46 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SION documents filed with the SEC.
SION Filings
Clear
